The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer
Abstract
The androgen receptor signaling axis plays an essential role in the development, function and homeostasis of male urogenital structures including the prostate gland although the mechanism by which the AR axis contributes to the initiation, progression and metastatic spread of prostate cancer remains somewhat enigmatic. A number of molecular events have been proposed to act at the level of the AR and associated coregulators to influence the natural history of prostate cancer including deregulated expression, somatic mutation, and post‐translational modification. The purpose of this article is to review the evidence for deregulated expression and function of the AR and associated coactivators and corepressors and how such events might contribute to the progression of prostate cancer by controlling the selection and expression of AR targets. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Gene expression correlates of clinical prostate cancer behavior
Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00030-2 · Cited by 2,512
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,465
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,292
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Taplin, M.-E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., & Balk, S. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322101 · Cited by 1,253
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M.-J., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,243
Caspase-3-Generated Fragment of Gelsolin: Effector of Morphological Change in Apoptosis
Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Chu, K., McGarry, T. J., Kirschner, M. W., Koths, K., Kwiatkowski, D. J., et al. (1997) · Science · doi:10.1126/science.278.5336.294 · Cited by 1,225
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., & Moras, D. (1995) · Nature · doi:10.1038/375377a0 · Cited by 1,177
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
The Endocrinology and Developmental Biology of the Prostate*
CUNHA, G. R., DONJACOUR, A. A., COOKE, P. S., MEE, H., BIGSBY, R. M., HIGGINS, S. J., & SUGIMURA, Y. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-3-338 · Cited by 1,036
Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
A canonical structure for the ligand-binding domain of nuclear receptors
Wurtz, J.-M., Bourguet, W., Renaud, J.-P., Vivat, V., Chambon, P., Moras, D., & Gronemeyer, H. (1996) · Nature Structural Biology · doi:10.1038/nsb0196-87 · Cited by 985
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 942
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
Role of CBP/P300 in nuclear receptor signalling
Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., & Evans, R. M. (1996) · Nature · doi:10.1038/383099a0 · Cited by 930
Coactivator and corepressor complexes in nuclear receptor function
Xu, L., Glass, C. K., & Rosenfeld, M. G. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80021-5 · Cited by 902
Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang‐Rodriguez, J., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M. (2001) · PubMed · Cited by 856
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-333 · Cited by 839
Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
Linja, M. J., Savinainen, K., Saramäki, O. R., Tammela, T. L. J., Vessella, R. L., & Visakorpi, T. (2001) · PubMed · Cited by 774
Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.158 · Cited by 758
Koivisto, P. A., Kononen, J., Palmberg, C., Tammela, T. L. J., HYYTINEN, E.-R., Isola, J. J., Trapman, J., Cleutjens, K. B. J. M., Noordzij, M. A., Visakorpi, T., et al. (1997) · PubMed · Cited by 728
Glass, C. K., Rose, D. W., & Rosenfeld, M. G. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80066-x · Cited by 698
Hong, H., Kohli, K., Trivedi, A., Johnson, D. L., & Stallcup, M. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4948 · Cited by 697
Formation of the Androgen Receptor Transcription Complex
Shang, Y., Myers, M., & Brown, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00471-9 · Cited by 672
SUMO-1 modification activates the transcriptional response of p53
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
Transcription Factor-Specific Requirements for Coactivators and Their Acetyltransferase Functions
Korzus, E., Torchia, J., Rose, D. W., Xu, L., Kurokawa, R., McInerney, E. M., Mullen, T.-M., Glass, C. K., & Rosenfeld, M. G. (1998) · Science · doi:10.1126/science.279.5351.703 · Cited by 632
Transcriptional activation and nuclear targeting signals of the human androgen receptor.
Simental, J. A., Sar, M., Lane, M. V., French, F. S., & Wilson, E. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52466-2 · Cited by 631
Gregory, C. W., He, B., Johnson, R. T., Ford, O. H., Mohler, J. L., French, F. S., & Wilson, E. (2001) · PubMed · Cited by 610
Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004571200 · Cited by 608
Wooster, R., & Weber, B. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012284 · Cited by 605
Solution Structure of the Glucocorticoid Receptor DNA-Binding Domain
Härd, T., Kellenbach, E., Boelens, R., Maler, B. A., Dahlman, K., Freedman, L. P., Carlstedt-Duke, J., Yamamoto, K. R., Gustafsson, J.-Å., & Kaptein, R. (1990) · Science · doi:10.1126/science.2115209 · Cited by 603
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.
Taplin, M., Bubley, G. J., Ko, Y., Small, E. J., Upton, M. P., Rajeshkumar, B. R., & Balk, S. P. (1999) · PubMed · Cited by 596
Yeh, S., Lin, H.-K., Kang, H.-Y., Thin, T. H., Lin, M.-F., & Chang, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5458 · Cited by 594
RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
Li, H., Gomes, P. J., & Chen, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8479 · Cited by 581
Lubahn, D. B., Joseph, D. R., Sar, M., Tan, J.-A., Higgs, H. N., Larson, R. E., French, F. S., & Wilson, E. M. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1265 · Cited by 570
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568
Steroid receptors and their associated proteins
Smith, D. F. (1993) · Molecular Endocrinology · doi:10.1210/me.7.1.4 · Cited by 545
Zhao, X.-Y., Malloy, P. J., Krishnan, A. V., Swami, S., Navone, N. M., Peehl, D. M., & Feldman, D. (2000) · Nature Medicine · doi:10.1038/76287 · Cited by 536
Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata, H., Spencer, T. E., Oñate, S. A., Jenster, G. W., Tsai, M., Tsai, M., & O’Malley, B. W. (1997) · PubMed · Cited by 520
Latulippe, É., Satagopan, J. M., Smith, A., Scher, H. I., Scardino, P. T., Reuter, V. E., & Gerald, W. L. (2002) · PubMed · Cited by 518
Familial breast-ovarian cancer locus on chromosome 17q12-q23
LENOIR, G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90076-2 · Cited by 517
CDC25 Phosphatases as Potential Human Oncogenes
Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., & Beach, D. (1995) · Science · doi:10.1126/science.7667636 · Cited by 504
Sack, J. S., Kish, K. F., Wang, C., Attar, R. M., Kiefer, S. E., An, Y., Wu, G. Y., Scheffler, J. E., Salvati, M. E., Krystek, S. R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081565498 · Cited by 491
Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. W., & Horwitz, K. B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.693 · Cited by 478
Wen, Y., Hu, M. C. ‐., Makino, K., Spohn, B., Bartholomeusz, G. A., Yan, D., & Hung, M. (2000) · PubMed · Cited by 461
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
Poukka, H., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14145 · Cited by 457
Role of Protein Methylation in Regulation of Transcription
Lee, D. Y., Teyssier, C., Strahl, B. D., & Stallcup, M. R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0008 · Cited by 455
Veldscholte, J., Berrevoets, C. A., Ris-Stalpers, C., Kuiper, G. G. J. M., Jenster, G., Trapman, J., Brinkmann, A. O., & Mulder, E. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90401-4 · Cited by 446
Hobisch, A., Eder, I. E., Putz, T., Horninger, W., Bartsch, G. C., Klocker, H., & Čulig, Z. (1998) · PubMed · Cited by 437
Ding, X. F., Anderson, C. M., Ma, H., Hong, H., Uht, R. M., Kushner, P. J., & Stallcup, M. R. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.2.0065 · Cited by 434
AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor
Font de Mora, J., & Brown, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5041-5047.2000 · Cited by 432
Activation of the human androgen receptor through a protein kinase A signaling pathway.
Nazareth, L. V., & Weigel, N. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19900 · Cited by 429
A New First Step in Activation of Steroid Receptors
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100531200 · Cited by 427
The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1
Bevan, C. L., Hoare, S., Claessens, F., Heery, D. M., & Parker, M. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8383 · Cited by 425
Jenster, G., van der Korput, H. A. G. M., Trapman, J., & Brinkmann, A. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7341 · Cited by 419
Zhou, Z. X. (1995) · Molecular Endocrinology · doi:10.1210/me.9.2.208 · Cited by 411
Fu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M.-L., & Pestell, R. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000660200 · Cited by 409
Structural basis of androgen receptor binding to selective androgen response elements
Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., & Gewirth, D. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401123101 · Cited by 400
c-Jun and p53 Activity Is Modulated by SUMO-1 Modification
Müller, S., Berger, M., Lehembre, F., Seeler, J.-S., Haupt, Y., & Dejean, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13321 · Cited by 400
Tilley, W. D., Buchanan, G., Hickey, T. E., & Bentel, J. M. (1996) · PubMed · Cited by 396
Self-citationExpression profiling reveals hepsin overexpression in prostate cancer.
Magee, J. A., Araki, T., Patil, S., Ehrig, T., True, L. D., Humphrey, P. A., Catàlona, W. J., Watson, M. A., & Milbrandt, J. (2001) · PubMed · Cited by 393
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
Taplin, M., & Balk, S. P. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10653 · Cited by 390
The histone acetylase PCAF is a nuclear receptor coactivator
Blanco, J. C. G., Minucci, S., Lu, J., Yang, X.-J., Walker, K. K., Chen, H., Evans, R. M., Nakatani, Y., & Ozato, K. (1998) · Genes & Development · doi:10.1101/gad.12.11.1638 · Cited by 388
Ueda, T., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108255200 · Cited by 381
Takeshita, A., Cardona, G. R., Koibuchi, N., Suen, C.-S., & Chin, W. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27629 · Cited by 378
Functions of gelsolin: motility, signaling, apoptosis, cancer
Kwiatkowski, D. J. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80012-x · Cited by 375
He, B., Kemppainen, J. A., Voegel, J. J., Gronemeyer, H., & Wilson, E. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37219 · Cited by 372
Beta-catenin mutations in human prostate cancer.
Voeller, H. J., Truica, C., & Gelmann, E. P. (1998) · PubMed · Cited by 371
Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene
Edwards, S. M., Kote-Jarai, Z., Meitz, J., Hamoudi, R., Hope, Q., Osin, P., Jackson, R., Southgate, C., Singh, R., Falconer, A., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345310 · Cited by 366
Androgen Receptor Phosphorylation
Gioeli, D., Ficarro, S. B., Kwiek, J. J., Aaronson, D., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 351
Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.
Truica, C. I., Byers, S. W., & Gelmann, E. P. (2000) · PubMed · Cited by 350
(1994) · PubMed Central · Cited by 328
FHL2, a novel tissue-specific coactivator of the androgen receptor
Muller, J. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.359 · Cited by 326
Enhanced Motility in NIH 3T3 Fibroblasts That Overexpress Gelsolin
Cunningham, C. C., Stossel, T. P., & Kwiatkowski, D. J. (1991) · Science · doi:10.1126/science.1848726 · Cited by 311
Ueda, T., Mawji, N. R., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203313200 · Cited by 311
Wu, R.-C., Qin, J., Yi, P., Wong, J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.019 · Cited by 296
He, B., Gampe, R. T., Kole, A. J., Hnat, A. T., Stanley, T. B., An, G., Stewart, E. L., Kalman, R. I., Minges, J. T., & Wilson, E. M. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.036 · Cited by 295
Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate
Fujimoto, N., Yeh, S., Kang, H.-Y., Inui, S., Chang, H.-C., Mizokami, A., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8316 · Cited by 294
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291
Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes
Kim, J. H., Kim, B., Cai, L., Choi, H. J., Ohgi, K. A., Tran, C., Chen, C., Chung, C. H., Huber, O., Rose, D. W., et al. (2005) · Nature · doi:10.1038/nature03452 · Cited by 291
Cunha, G. R., Fujii, H., Neubauer, B. L., Shannon, J. M., Sawyer, L., & Reese, B. A. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.6.1662 · Cited by 287
Characterization of YDJ1: a yeast homologue of the bacterial dnaJ protein.
Caplan, A. J., & Douglas, M. G. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.4.609 · Cited by 277
Fu, M., Rao, M., Wang, C., Sakamaki, T., Wang, J., Di Vizio, D., Zhang, X., Albanese, C., Balk, S., Chang, C., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8563-8575.2003 · Cited by 277
Dong, Y., Hakimi, M.-A., Chen, X., Kumaraswamy, E., Cooch, N. S., Godwin, A. K., & Shiekhattar, R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00424-6 · Cited by 276
Sadar, M. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7777 · Cited by 270
The androgen receptor gene mutations database
Gottlieb, B. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.151 · Cited by 268
Phosphorylation of Steroid Receptor Coactivator-1
Rowan, B. G., Weigel, N. L., & O'Malley, B. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4475 · Cited by 268
CREB-binding protein in androgen receptor-mediated signaling
Aarnisalo, P., Palvimo, J. J., & Jänne, O. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2122 · Cited by 255
Tip60 Is a Nuclear Hormone Receptor Coactivator
Brady, M. E., Ozanne, D. M., Gaughan, L., Waite, I., Cook, S., Neal, D. E., & Robson, C. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17599 · Cited by 255
Androgen receptors in prostate cancer.
Culig, Z., Klocker, H., Bartsch, G., & Hobisch, A. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090155 · Cited by 247
SRC-3 Is Required for Prostate Cancer Cell Proliferation and Survival
Zhou, H.-J., Yan, J., Luo, W., Ayala, G., Lin, S.-H., Erdem, H., Ittmann, M., Tsai, S. Y., & Tsai, M.-J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4076 · Cited by 246
Androgens induce divergent proliferative responses in human breast cancer cell lines
Birrell, S. N., Bentel, J. M., Hickey, T. E., Ricciardelli, C., Weger, M. A., Horsfall, D. J., & Tilley, W. D. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00005-k · Cited by 245
Self-citationRole of molecular chaperones in steroid receptor action
Pratt, W. B., Galigniana, M. D., Morishima, Y., & Murphy, P. J. M. (2004) · Essays in Biochemistry · doi:10.1042/bse0400041 · Cited by 242
Sadi, M. V., Walsh, P. C., & Barrack, E. R. (1991) · Cancer · doi:10.1002/1097-0142(19910615)67:12<3057::aid-cncr2820671221>3.0.co;2-s · Cited by 240
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
Scher, H. I., Buchanan, G., Gerald, W., Butler, L. M., & Tilley, W. D. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00525 · Cited by 240
Self-citationThe Assembly of Progesterone Receptor-hsp90 Complexes Using Purified Proteins
Kosano, H., Stensgard, B., Charlesworth, M. C., McMahon, N., & Toft, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32973 · Cited by 240
Gene expression analysis of prostate cancers
Luo, J., Yu, Y. P., Cieply, K., Lin, F., Deflavia, P., Dhir, R., Finkelstein, S., Michalopoulos, G., & Becich, M. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10018 · Cited by 235
Harris, T. E., & Lawrence, J. C. (2003) · Science's STKE · doi:10.1126/stke.2122003re15 · Cited by 234
Langley, E., Kemppainen, J. A., & Wilson, E. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.92 · Cited by 233
Kang, H.-Y., Yeh, S., Fujimoto, N., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8570 · Cited by 230
Structural and functional consequences of glutamine tract variation in the androgen receptor
Buchanan, G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh181 · Cited by 225
Self-citationCREB Binding Protein Is a Coactivator for the Androgen Receptor and Mediates Cross-talk with AP-1
Frønsdal, K., Engedal, N., Slagsvold, T., & Saatcioglu, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31853 · Cited by 222
Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation
Claessens, F., Verrijdt, G., Schoenmakers, E., Haelens, A., Peeters, B., Verhoeven, G., & Rombauts, W. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00154-0 · Cited by 222
Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.
Drobnjak, M., Osman, I., Scher, H. I., Fazzari, M. J., & Cordon‐Cardo, C. (2000) · PubMed · Cited by 221
Hsiao, P.-W., Lin, D.-L., Nakao, R., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20229 · Cited by 221
p300 in prostate cancer proliferation and progression.
Debes, J. D., Sebo, T. J., Lohse, C. M., Murphy, L. M., Haugen, D. A. L., & Tindall, D. J. (2003) · PubMed · Cited by 219
Expression of metalloproteinase genes in human prostate cancer
Pajouh, M. S., Nagle, R. B., Breathnach, R., Finch, J. S., Brawer, M. K., & Bowden, G. T. (1991) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01613138 · Cited by 218
BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
Chen, J. J., Silver, D. P., Cantor, S., Livingston, D. M., & Scully, R. (1999) · PubMed · Cited by 217
Prevalent mutations in prostate cancer
Dong, J. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20696 · Cited by 217
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
Ayala, G., Wang, D.-G., Wulf, G. M., Frolov, A., Li, R., Sowadski, J. M., Wheeler, T. M., Lu, K. P., & Bao, L. (2003) · PubMed · Cited by 216
Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development
Halkidou, K., Gnanapragasam, V. J., Mehta, P. B., Logan, I. R., Brady, M. E., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2003) · Oncogene · doi:10.1038/sj.onc.1206342 · Cited by 214
Lee, S.-K., Anzick, S. L., Choi, J.-E., Bubendorf, L., Guan, X.-Y., Jung, Y.-K., Kallioniemi, O. P., Kononen, J., Trent, J. M., Azorsa, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34283 · Cited by 213
Is the Achilles’ Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?
Litvinov, I. V., De Marzo, A. M., & Isaacs, J. T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022038 · Cited by 213
Schaufele, F., Carbonell, X., Guerbadot, M., Borngraeber, S., Chapman, M. S., Ma, A. A. K., Miner, J. N., & Diamond, M. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408819102 · Cited by 208
Henshall, S. M., Quinn, D. I., Lee, C. S., Head, D. R., Golovsky, D., Brenner, P. C., Delprado, W., Stricker, P. D., Grygiel, J. J., & Sutherland, R. L. (2001) · PubMed · Cited by 208
Bakin, R. E., Gioeli, D. G., Sikes, R. A., Bissonette, E. A., & Weber, M. J. (2003) · PubMed · Cited by 201
Epidermal Growth Factor Increases Coactivation of the Androgen Receptor in Recurrent Prostate Cancer
Gregory, C. W., Fei, X., Ponguta, L. A., He, B., Bill, H. M., French, F. S., & Wilson, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307649200 · Cited by 201
Nagata, A., Igarashi, M., Jinno, S., et al. (1991) · PubMed · Cited by 199
Hold 'em and Fold 'em: Chaperones and Signal Transduction
Bohen, S. P., Kralli, A., & Yamamoto, K. R. (1995) · Science · doi:10.1126/science.7761850 · Cited by 196
Zhou, J., Ng, S., Adesanya-Famuiya, O., Anderson, K., & Bondy, C. A. (2000) · The FASEB Journal · doi:10.1096/fj.99-0863com · Cited by 193
Mutation of the androgen receptor causes oncogenic transformation of the prostate.
Han, G., Buchanan, G., Ittmann, M., Harris, J. M., Yu, X., DeMayo, F. J., Tilley, W., & Greenberg, N. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408925102 · Cited by 192
Self-citationExpression of RAC 3, a steroid hormone receptor co-activator in prostate cancer
Gnanapragasam, V. J., Leung, H. Y., Pulimood, A. S., Neal, D. E., & Robson, C. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2179 · Cited by 189
The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators
He, B., Minges, J. T., Lee, L. W., & Wilson, E. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111975200 · Cited by 189
Identification of three proline-directed phosphorylation sites in the human androgen receptor
Zhou, Z. X. (1995) · Molecular Endocrinology · doi:10.1210/me.9.5.605 · Cited by 186
Gelsolin: a candidate for suppressor of human bladder cancer.
Tanaka, M., Müllauer, L., Ogiso, Y., Fujita, H., Moriya, S., Furuuchi, K., Harabayashi, T., Shinohara, N., Koyanagi, T., & Kuzumaki, N. (1995) · PubMed · Cited by 186
Lin, H.-K., Hu, Y.-C., Yang, L., Altuwaijri, S., Chen, Y.-T., Kang, H.-Y., & Chang, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300676200 · Cited by 186
Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT
Liao, G., Chen, L.-Y., Zhang, A., Godavarthy, A., Xia, F., Ghosh, J. C., Li, H., & Chen, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206374200 · Cited by 183
Collocation of androgen receptor gene mutations in prostate cancer.
Buchanan, G., Greenberg, N. M., Scher, H. I., Harris, J. M., Marshall, V. R., & Tilley, W. D. (2001) · PubMed · Cited by 181
Self-citationMcEwan, I. J., & Gustafsson, J.-Å. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8485 · Cited by 176
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.
Park, J. M., Irvine, R. A., Buchanan, G., Koh, S. S., Park, J. M., Tilley, W. D., Stallcup, M. R., Press, M. F., & Coetzee, G. A. (2000) · PubMed · Cited by 168
Self-citationDependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction
He, B., Lee, L. W., Minges, J. T., & Wilson, E. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202809200 · Cited by 167
Identification and Characterization of a Ligand-regulated Nuclear Export Signal in Androgen Receptor
Saporita, A. J., Zhang, Q., Navai, N., Dincer, Z., Hahn, J., Cai, X., & Wang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302460200 · Cited by 167
Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
Buchanan, G., Irvine, R. A., Coetzee, G. A., & Tilley, W. D. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015531326689 · Cited by 165
Self-citationDistinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells
Gross, M., Liu, B., Tan, J.-A., French, F. S., Carey, M., & Shuai, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204489 · Cited by 164
Owens-Grillo, J. K., Czar, M. J., Hutchison, K. A., Hoffmann, K., Perdew, G. H., & Pratt, W. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13468 · Cited by 163
Dittmar, K. D., Banach, M., Galigniana, M. D., & Pratt, W. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7358 · Cited by 163
Overexpression of CDC25A and CDC25B in head and neck cancers.
Gasparotto, D., Maestro, R., Piccinin, S., Vukosavljevic, T., Barzan, L., Sulfaro, S., & Boiocchi, M. (1997) · PubMed · Cited by 161
Chesire, D. R., Ewing, C. M., Gage, W. R., & Isaacs, W. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205352 · Cited by 161
Li, P., Lee, H., Guo, S., Unterman, T. G., Jenster, G., & Bai, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.104-118.2003 · Cited by 160
Schoenmakers, E., Alen, P., Verrijdt, G., Peeters, B., Verhoeven, G., Rombauts, W., & Claessens, F. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410515 · Cited by 158
The mediator coactivator complex: functional and physical roles in transcriptional regulation
Lewis, B. A., & Reinberg, D. (2003) · Journal of Cell Science · doi:10.1242/jcs.00734 · Cited by 158
Chodak, G. W., Kranc, D. M., Puy, L. A., Takeda, H., Johnson, K. L., & Chang, C. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37389-5 · Cited by 157
Lopez, G. N., Turck, C. W., Schaufele, F., Stallcup, M. R., & Kushner, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010718200 · Cited by 154
A Testis-specific Androgen Receptor Coregulator That Belongs to a Novel Family of Nuclear Proteins
Moilanen, A., Karvonen, U., Poukka, H., Yan, W., Toppari, J., Jänne, O. A., & Palvimo, J. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3700 · Cited by 154
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
TAILLE, A. D. L., Rubin, M. A., Chen, M., Vacherot, F., de Medina, S. G. D., Burchardt, M., Buttyan, R., & Chopin, D. K. (2003) · PubMed · Cited by 151
Yeh, S., Hu, Y., Rahman, M. M., Lin, H., Hsu, C.-L., Ting, H., Kang, H., & Chang, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190353897 · Cited by 151
Hodgson, M. C., Astapova, I. I., Cheng, S., Lee, L. J., Verhoeven, M. C., Choi, E., Balk, S. P., & Hollenberg, A. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408972200 · Cited by 149
The Amino Terminus of the Human AR Is Target for Corepressor Action and Antihormone Agonism
Dotzlaw, H., Moehren, U., Mink, S., Cato, A. C. B., Iñiguez-Lluhí, J. A., & Baniahmad, A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0798 · Cited by 145
He, B., Bai, S., Hnat, A. T., Kalman, R. I., Minges, J. T., Patterson, C., & Wilson, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403117200 · Cited by 144
Cyclin D1: Mechanism and Consequence of Androgen Receptor Co-repressor Activity
Petre, C. E., Wetherill, Y. B., Danielsen, M., & Knudsen, K. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106399200 · Cited by 144
Conformational Analysis of the Androgen Receptor Amino-terminal Domain Involved in Transactivation
Reid, J., Kelly, S. M., Watt, K., Price, N. C., & McEwan, I. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201003200 · Cited by 143
Hsiao, P., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22373 · Cited by 142
Expression of Androgen Receptor Coregulators in Prostate Cancer
Linja, M. J., Porkka, K. P., Kang, Z., Savinainen, K., Jänne, O. A., Tammela, T. L. J., Vessella, R. L., Palvimo, J. J., & Visakorpi, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0990-3 · Cited by 141
Dong, X.-Y., Chen, C., Sun, X., Guo, P., Vessella, R. L., Wang, R.-X., Chung, L. W. K., Zhou, W., & Dong, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0411 · Cited by 140
Faber, P. W., van Rooij, H. C., Schipper, H. J., Brinkmann, A. O., & Trapman, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98349-3 · Cited by 138
Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer
Li, P., Yu, X., Ge, K., Melamed, J., Roeder, R. G., & Wang, Z. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64422-7 · Cited by 137
Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor
Belandia, B., Powell, S. M., Garcia-Pedrero, J. M., Walker, M. M., Bevan, C. L., & Parker, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1425-1436.2005 · Cited by 137
The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer
Chatterjee, B. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026057402945 · Cited by 135
Grad, J. M., Dai, J. L., Wu, S., & Burnstein, K. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.11.0369 · Cited by 135
The Androgen Receptor Gene Mutations Database
Gottlieb, B. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.234 · Cited by 135
Partner proteins determine multiple functions of Hsp70
Rassow, J., Voos, W., & Pfanner, N. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89001-7 · Cited by 134
BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF
Link, K. A., Burd, C. J., Williams, E., Marshall, T. W., Rosson, G. B., Henry, E. C., Weissman, B. E., & Knudsen, K. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2200-2215.2005 · Cited by 134
Androgen Receptor: Structural Domains and Functional Dynamics after Ligand‐Receptor Interaction
Roy, A. K., Tyagi, R. K., Song, C. S., Lavrovsky, Y., Ahn, S., Oh, T., & Chatterjee, B. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb04001.x · Cited by 132
Schoenmakers, E., Verrijdt, G., Peeters, B. P. H., Verhoeven, G., Rombauts, W., & Claessens, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12290 · Cited by 132
Yang, L., Xie, S., Jamaluddin, M. S., Altuwaijri, S., Ni, J., Kim, E., Chen, Y.-T., Hu, Y.-C., Wang, L., Chuang, K.-H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504461200 · Cited by 131
hZimp10 is an androgen receptor co‐activator and forms a complex with SUMO‐1 at replication foci
Sharma, M., Li, X., Wang, Y., Zarnegar, M. A., Huang, C., Palvimo, J. J., Lim, B., & Sun, Z. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg585 · Cited by 131
The Nuclear Receptor Interaction Domain of GRIP1 Is Modulated by Covalent Attachment of SUMO-1
Kotaja, N., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204768200 · Cited by 130
Role of the androgen receptor in human breast cancer.
Birrell, S. N., Hall, R. E., & Tilley, W. D. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018730519839 · Cited by 124
Self-citationHan, G., Foster, B. A., Mistry, S. G., Buchanan, G., Harris, J. M., Tilley, W. D., & Greenberg, N. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008207200 · Cited by 123
Self-citationDefining a minimal estrogen receptor DNA binding domain
Mader, S., Chambon, P., & White, J. H. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.5.1125 · Cited by 123
Buchanan, G., Yang, M., Harris, J. M., Nahm, H. S., Han, G., Moore, N. L. T., Bentel, J. M., Matusik, R. J., Horsfall, D. J., Marshall, V. R., et al. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.1.0581 · Cited by 122
Self-citationStallcup, M. R., Kim, J. H., Teyssier, C., Lee, Y., Ma, H., & Chen, D. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00222-x · Cited by 121
Yoon, H.-G., & Wong, J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0324 · Cited by 120
Different expression of androgen receptor coactivators in human prostate
Fujimoto, N., Mizokami, A., Harada, S., & Matsumoto, T. (2001) · Urology · doi:10.1016/s0090-4295(01)01117-7 · Cited by 120
Widespread loss of gelsolin in breast cancers of humans, mice, and rats.
Asch, H. L., Head, K. L., Dong, Y., Natoli, F., Winston, J. S., Connolly, J. L., & Asch, B. B. (1996) · PubMed · Cited by 120
Belandia, B., & Parker, M. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00599-3 · Cited by 118
Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer
Ngan, E., Hashimoto, Y., Ma, Z.-Q., Tsai, M., & Tsai, S. Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206121 · Cited by 118
From Androgen Receptor to the General Transcription Factor TFIIH
Lee, D. K., Duan, H. O., & Chang, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9308 · Cited by 117
Ricciardelli, C., Choong, C. S., Buchanan, G., Vivekanandan, S., Neufing, P. J., Stahl, J., Marshall, V. R., Horsfall, D. J., & Tilley, W. D. (2004) · The Prostate · doi:10.1002/pros.20154 · Cited by 116
Self-citationČulig, Z., Klocker, H., Eberle, J., Kaspar, F., Hobisch, A., Cronauer, M. V., & Bartsch, G. H. (1993) · The Prostate · doi:10.1002/pros.2990220103 · Cited by 115
Nishimura, K., Ting, H., Harada, Y., Tokizane, T., Nonomura, N., Kang, H., Chang, H., Yeh, S., Miyamoto, H., Shin, M., et al. (2003) · PubMed · Cited by 115
Negative Modulation of Androgen Receptor Transcriptional Activity by Daxx
Lin, D.-Y., Fang, H.-I., Ma, A., Huang, Y., Pu, Y., Jenster, G. W., Kung, H.-J., & Shih, H.-M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10529-10541.2004 · Cited by 113
A Coregulatory Role for the TRAP-Mediator Complex in Androgen Receptor-mediated Gene Expression
Wang, Q., Sharma, D., Ren, Y., & Fondell, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206061200 · Cited by 112
Interplay between two hormone-independent activation domains in the androgen receptor.
Callewaert, L., Van Tilborgh, N., & Claessens, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2389 · Cited by 111
Molecular chaperones throughout the life cycle of the androgen receptor
Prescott, J., & Coetzee, G. A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.037 · Cited by 111
Comuzzi, B., Nemes, C., Schmidt, S. U., Jasarevic, Z., Lodde, M., Pycha, A., Bartsch, G. H., Offner, F. A., Čulig, Z., & Hobisch, A. (2004) · The Journal of Pathology · doi:10.1002/path.1609 · Cited by 109
Research works printed but not linked: 16
- 10.1111/j.1432-0436.1983.tb01317.x · doi:10.1111/j.1432-0436.1983.tb01317.x
- Cunha GR, 1984, Androgenic effects upon prostatic epithelium are mediated via trophic influences from stroma, Prog Clin Biol Res, 145, 81
- 10.1111/j.1432-0436.2005.00047.x · doi:10.1111/j.1432-0436.2005.00047.x
- 10.1038/bjc.1998.142 · doi:10.1038/bjc.1998.142
- 10.1210/er.20.3.321 · DOI
- 10.1002/1097-0045(20001001)45:2<124::AID-PROS6>3.0.CO;2-7 · doi:10.1002/1097-0045(20001001)45:2<124::aid-pros6>3.0.co;2-7
- 10.1002/(SICI)1521-1878(199810)20:10<860::AID-BIES12>3.0.CO;2-S · doi:10.1002/(sici)1521-1878(199810)20:10<860::aid-bies12>3.0.co;2-s
- 10.1042/bj3410515 · DOI · Paper page
- 10.1210/me.13.9.1558 · DOI
- 10.1210/er.18.3.306 · DOI
- 10.1002/(SICI)1097-0045(19990615)40:1<14::AID-PROS2>3.0.CO;2-6 · doi:10.1002/(sici)1097-0045(19990615)40:1<14::aid-pros2>3.0.co;2-6
- Chang HC, 2005, In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen‐dependent prostate cancer cell line, J Formos Med Assoc, 104, 652
- 10.1210/mend.11.6.0004 · doi:10.1210/mend.11.6.0004 · Paper page
- 10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F · doi:10.1002/(sici)1097-0045(19980501)35:2<95::aid-pros2>3.0.co;2-f
- 10.1002/pros.20278 · DOI
- 10.1093/jnci/djh006 · DOI
Cited by
Locke, J. A., Guns, E. S., Lubik, A. A., Adomat, H. H., Hendy, S. C., Wood, C. A., Ettinger, S. L., Gleave, M. E., & Nelson, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5997 · Cited by 747
AR, the cell cycle, and prostate cancer
Balk, S. P., & Knudsen, K. E. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06001 · Cited by 333
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Knudsen, K. E., & Scher, H. I. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2660 · Cited by 307
Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
Knudsen, K. E., & Penning, T. M. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.01.002 · Cited by 293
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
Metadata
- Authors
- Chmelar, R., Buchanan, G., Need, E. F., Tilley, W., & Greenberg, N. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-12-27
- Volume
- 120
- Issue
- 4
- Pages
- 719-733
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2010246016
- Cited by
- 255
- References
- 263
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- National Cancer Institute (NMG) (CA73747, CA84296)
- National Health and Medical Research Council of Australia (WDT) (299048)
- US Department of Defense (W81XWH-04-1-0017)
- NHMRC CJ Martin Biomedical Fellowship
- Florey Adelaide Male Aging Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.